Skip to main content

Table 4 Answers to PAD questionnaire applied to investigators expressed as n(%) (n = 53)

From: Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis - CAREFUL Study: A national, multi-center, cross-sectional observational study

In which age group (years) of your patients do you consider to measure ABI in your clinic?
  55-59 60-64 65-69 70-74 75-79 ≥80
For male patients 40 (75.5) 29 (54.7) 31 (58.5) 21 (39.6) 20 (37.7) 17 (32.1)
For female patients 31 (58.5) 31 (58.5) 32 (60.4) 21 (39.6) 20 (37.7) 17 (32.1)
Do you evaluate obese patients by physical examination and ABI with the suspect of PAD?
Yes 24(45.3)
Do you evaluate diabetic patients by physical examination and ABI with the suspect of PAD
Yes 35(66.0)
Do you evaluate smokers by physical examination and ABI with the suspect of PAD?
Yes 33(62.5)
What are the objectives of PAD treatment according to Turkish Society of Cardiovascular Surgery?
To control symptoms 39(73.6)
To prevent amputation 45(84.9)
To increase survival 46(86.8)
Do "patient history" and "physical examination" show that your patient has PAD?
Yes 12(22.6)
What should be the option(s) of your patient for the further investigation of PAD?
ABI + Doppler 50(94.3)
Cardiovascular surgery consultation 16(30.2)
Nothing, routine follow up 3(5.7)
What are the treatments of choice for ischemic events?
  Continue Add Stop Contraindicate
ASA 48(92.5) 16(30.2) 0(0.0) 0(0.0)
Clopidogrel 30(56.6) 28(52.8) 0(0.0) 0(0.0)
Cilostazole 9(17) 12(22.6) 0(0.0) 0(0.0)
Statins 41(77.4) 24(45.3) 0(0.0) 0(0.0)
Other lipid lowering drugs 26(49.1) 22(41.5) 1(1.9) 0(0.0)
ACE inhibitors 38(71.7) 21(39.6 0(0.0) 0(0.0)
Other antihypertensives 24(45.3) 24(45.3) 3(5.7) 1(1.9)
Warfarin 23(43.4) 21(39.6) 3(5.7) 0(0.0)
Antihyperglycemic drug 40(75.5) 17(32.1) 0(0.0) 0(0.0)
Stop smoking program 45(85.9) 20(37.7) 1(1.9) 1(1.9)
Walking-exercise prog. 43(81.1) 23(43.4) 1(1.9) 0(0.0)